What are the characteristic facial features of Noonan syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Characteristic Facial Features of Noonan Syndrome

Noonan syndrome presents with distinctive facial dysmorphology characterized by hypertelorism, downslanting palpebral fissures, ptosis, low-set posteriorly rotated ears with thickened helix, a broad forehead, and a short nose with a broad base and bulbous tip. 1, 2

Core Facial Features

Ocular Characteristics

  • Hypertelorism (widely spaced eyes) is present in 31-100% of patients and represents one of the most consistent findings 1, 3
  • Downslanting palpebral fissures are a hallmark feature 1, 2, 4
  • Ptosis (drooping eyelids) occurs frequently 1, 2
  • Epicanthal folds are commonly observed, particularly in infancy 1, 4

Nasal and Midface Features

  • Short nose with broad nasal base and bulbous tip is characteristic 1, 5
  • Increased mid-face height has been objectively documented through photoanthropometric analysis 5
  • Lower nasal bridge and nasal root compared to normal controls 5

Auricular Features

  • Low-set, posteriorly rotated ears with thickened helix are typical 2, 4
  • Ears appear posteriorly angulated 1

Craniofacial Structure

  • Broad forehead with bitemporal narrowing in some variants 1
  • Relative macrocephaly is common 1
  • Retrognathia (small, receding chin) is frequently present 5
  • Wider mouth with full lips 5
  • Prominent upper lip 5

Age-Related Facial Changes

Infancy and Early Childhood

  • Full cheeks and flat facial profile predominate in infants 6
  • Epicanthal folds are more prominent during this period 6

Adolescence and Adulthood

  • Facial features may become less pronounced with age 1
  • Narrow face and long neck often develop in older children and adults 6
  • Facial remodeling continues into adult life, with characteristic features evolving over time 5

Distinguishing Features from Related RASopathies

Noonan syndrome has less coarse facial features compared to Cardio-Facio-Cutaneous (CFC) syndrome and Costello syndrome, which helps differentiate these conditions clinically 1. Unlike CFC syndrome, NS patients have:

  • Fewer cutaneous features such as follicular hyperkeratosis 1
  • Less sparse eyebrows 1
  • Lower incidence of ulerythema ophryogenes 1

Clinical Significance

Recognition of these facial features is critical for early diagnosis, as they often serve as the first diagnostic clues when coupled with cardiac disease, feeding difficulties, and developmental delay 1. The facial phenotype shows sufficient consistency across populations, including African descent individuals, where facial analysis algorithms can discriminate NS patients from unaffected individuals with high accuracy (AUC 0.94-0.979) 3.

Molecular confirmation through genetic testing is essential once clinical features suggest NS, as approximately 50% of cases have PTPN11 mutations, with other genes including SOS1, RAF1, and KRAS accounting for additional cases 2, 7. The specific genetic variant can influence prognosis and guide treatment decisions, particularly regarding cardiac manifestations 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.